292 Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian, fallopian tube or primary peritoneal cancer: our experience in 108 patients

ME Capilna; B Moldovan; C Rad; AA Moldovan; AL Cozlea; A Fandi; M Gheorghe; SL Kiss

doi:10.1136/ijgc-2019-IGCS.292

Article info

PDF

E-Poster viewings

Ovarian Cancer

IGCS19-0208

292 Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian, fallopian tube or primary peritoneal cancer: our experience in 108 patients

Free

Authors

ME Capilna 1University of Medicine- Pharmacy- Science and Technology, First Obstetrics and Gynecology Clinic, Targu Mures, Romania PubMed articles Google scholar articles
B Moldovan 2St. Constantin Hospital, Department of General Surgery, Brasov, Romania PubMed articles Google scholar articles
C Rad 2St. Constantin Hospital, Department of General Surgery, Brasov, Romania PubMed articles Google scholar articles
AA Moldovan 3St. Constantin Hospital, Department of Epidemiology and Infectious Diseases, Brasov, Romania PubMed articles Google scholar articles
AL Cozlea 1University of Medicine- Pharmacy- Science and Technology, First Obstetrics and Gynecology Clinic, Targu Mures, Romania PubMed articles Google scholar articles
A Fandi 1University of Medicine- Pharmacy- Science and Technology, First Obstetrics and Gynecology Clinic, Targu Mures, Romania PubMed articles Google scholar articles
M Gheorghe 1University of Medicine- Pharmacy- Science and Technology, First Obstetrics and Gynecology Clinic, Targu Mures, Romania PubMed articles Google scholar articles
SL Kiss 1University of Medicine- Pharmacy- Science and Technology, First Obstetrics and Gynecology Clinic, Targu Mures, Romania PubMed articles Google scholar articles

Citation

Capilna M, Moldovan B, Rad C, et al

292 Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian, fallopian tube or primary peritoneal cancer: our experience in 108 patients

International Journal of Gynecologic Cancer 2019;29:A122.

Publication history

First published September 18, 2019.

Online issue publication

September 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password